There has been, naturally, a good deal of interest in the Covid-19 vaccines about to be rolled out, as they will be vital for all CLL patients and their families. With this in mind, we invited an expert to give us his views and to answer questions from our members. We heard from Prof. Saul Faust of the University of Southampton, who has been a member of the NIHR COVID-19 vaccine trial delivery group, and Dr Renata Walewska, chair of the UK CLL Forum.